Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beinaglutide plus metformin for obese polycystic ovary syndrome
ChiCTR2000033741Phase 4Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Jun 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beinaglutide and metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Body mass index, Prolactin and 9 more. Started Jun 2020; status: recruiting.
02
Drugs
beinaglutidemetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2000033741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033741.